Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer

British Journal of Cancer

Volumn 113, Issue 2, 2015, Pages 275-281

  Matsumura, T ^a,b   Sugimachi, K ^a   Iinuma, H ^c   Takahashi, Y ^a,b   Kurashige, J ^a   Sawada, G ^a   Ueda, M ^a,b   Uchi, R ^a   Ueo, H ^a   Takano, Y ^a   Shinden, Y ^a   Eguchi, H ^a   Yamamoto, H ^b   Doki, Y ^b   Mori, M ^b   Ochiya, T ^d   Mimori, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1204; MICRORNA 1246; MICRORNA 1288; MICRORNA 146A; MICRORNA 151B; MICRORNA 16-2; MICRORNA 17; MICRORNA 17 92A; MICRORNA 185; MICRORNA 199A 3P; MICRORNA 199B 3P; MICRORNA 19A; MICRORNA 19B; MICRORNA 223; MICRORNA 23A; MICRORNA 302C; MICRORNA 3150A 5P; MICRORNA 320A; MICRORNA 320C; MICRORNA 320D; MICRORNA 3618; MICRORNA 3681; MICRORNA 4437; MICRORNA 4478; MICRORNA 548V; MICRORNA 642B; MICRORNA 761; MICRORNA 92A; MICRORNA MIR 191; UNCLASSIFIED DRUG; MIRN17-92 MICRORNA, HUMAN; MIRN19 MICRORNA, HUMAN; TUMOR MARKER;

AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXOSOME; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MALE; MEMBRANE MICROPARTICLE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; BLOOD; COLORECTAL NEOPLASMS; GENETICS; PATHOLOGY; PROGNOSIS; TUMOR RECURRENCE;

BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; EXOSOMES; HUMANS; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 84937073193     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.201     Document Type: Article

References (35)

1. Akiyoshi T, Kobunai T, Watanabe T (2012) Recent approaches to identifying biomarkers for high-risk stage II colon cancer. Surg Today 42(11): 1037-1045.
2. Amano R, Yamada N, Nakata B, Kimura K, Yashiro M, Ohira M, Hirakawa K (2014) Prognostic indicator for the resection of liver metastasis of colorectal cancer. Surg Today 44(7): 1287-1292.
3. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11): 857-866.
4. Cortez MA, Welsh JW, Calin GA (2012) Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res 195: 151-161.
5. Davoren PA, McNeill RE, Lowery AJ, Kerin MJ, Miller N (2008) Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 9: 76.
6. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, Meijerink WJ, Carvalho B, Meijer GA (2009) MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 101(4): 707-714.
7. Feng Y, Liu J, Kang Y, He Y, Liang B, Yang P, Yu Z (2014) miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer. J Exp Clin Cancer Res 33: 67.
8. Field K, Lipton L (2007) Metastatic colorectal cancer-past, progress and future. World J Gastroenterol 13(28): 3806-3815.
9. Ge Q, Zhou Y, Lu J, Bai Y, Xie X, Lu Z (2014) miRNA in plasma exosome is stable under different storage conditions. Molecules 19(2): 1568-1575.
10. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65(21): 9628-9632.
11. Hoshino I, Matsubara H (2013) MicroRNAs in cancer diagnosis and therapy: from bench to bedside. Surg Today 43(5): 467-478.
12. Komatsu S, Ichikawa D, Hirajima S, Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Arita T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Yagi N, Otsuji E (2014) Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma. Br J Cancer 111(8): 1614-1624.
13. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285(23): 17442-17452.
14. Kowal J, Tkach M, Thery C (2014) Biogenesis and secretion of exosomes. Curr Opin Cell Biol 29: 116-125.
15. Li Z, Rana TM (2014) Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov 13(8): 622-638.
16. Liang Z, Li Y, Huang K, Wagar N, Shim H (2011) Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN. Pharm Res 28(12): 3091-3100.
17. Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G (2011) GISTIC2. 0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 12: R41.
18. Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H, Watanabe M, Nakagama H, Yokota J, Kohno T, Tsuchiya N (2014) Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One 9(4): e92921.
19. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ, He L (2009) miR-19 is a key oncogenic component of mir-17-92. Genes Dev 23(24): 2839-2849.
20. Olive V, Jiang I, He L (2010) mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42(8): 1348-1354.
21. Palma J, Yaddanapudi SC, Pigati L, Havens MA, Jeong S, Weiner GA, Weimer KM, Stern B, Hastings ML, Duelli DM (2012) MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res 40(18): 9125-9138.
22. Pan BT, Johnstone RM (1983) Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33(3): 967-978.
23. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F (2012) Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380(9856): 1840-1850.
24. Sugimachi K, Matsumura T, Hirata H, Uchi R, Ueda M, Ueo H, Shinden Y, Iguchi T, Eguchi H, Shirabe K, Ochiya T, Maehara Y, Mimori K (2015) Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation. Br J Cancer 112(3): 532-538.
25. Tan W, Li Y, Lim SG, Tan TM (2014) miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma. World J Gastroenterol 20(20): 5962-5972.
26. Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M, Baba H (2013) Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer 119(6): 1159-1167.
27. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6): 654-659.
28. van der Meel R, Fens MH, Vader P, van Solinge WW, Eniola-Adefeso O, Schiffelers RM (2014) Extracellular vesicles as drug delivery systems: lessons from the liposome field. J Control Release 195: 72-85.
29. Wang F, Li T, Zhang B, Li H, Wu Q, Yang L, Nie Y, Wu K, Shi Y, Fan D (2013) MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem Biophys Res Commun 434(3): 688-694.
30. Xue W, Dahlman JE, Tammela T, Khan OF, Sood S, Dave A, Cai W, Chirino LM, Yang GR, Bronson R, Crowley DG, Sahay G, Schroeder A, Langer R, Anderson DG, Jacks T (2014) Small RNA combination therapy for lung cancer. Proc Natl Acad Sci USA 111(34): E3553-E3561.
31. Yamamoto Y, Yoshioka Y, Minoura K, Takahashi RU, Takeshita F, Taya T, Horii R, Fukuoka Y, Kato T, Kosaka N, Ochiya T (2011) An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells. Mol Cancer 10: 135.
32. Yoshioka Y, Kosaka N, Konishi Y, Ohta H, Okamoto H, Sonoda H, Nonaka R, Yamamoto H, Ishii H, Mori M, Furuta K, Nakajima T, Hayashi H, Sugisaki H, Higashimoto H, Kato T, Takeshita F, Ochiya T (2014a) Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun 5: 3591.
33. Yoshioka Y, Uehara K, Ebata T, Yokoyama Y, Mitsuma A, Ando Y, Nagino M (2014b) Postoperative complications following neoadjuvant bevacizumab treatment for advanced colorectal cancer. Surg Today 44(7): 1300-1306.
34. Zhang J, Xiao Z, Lai D, Sun J, He C, Chu Z, Ye H, Chen S, Wang J (2012) miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer. Br J Cancer 107(2): 352-359.
35. Zheng G, Du L, Yang X, Zhang X, Wang L, Yang Y, Li J, Wang C (2014) Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma. Br J Cancer 111(10): 1985-1992.